Hyperion DeFi

HYPD · NASDAQ

$2.98+$0.115 (+4.02%)TodayMarket closed ·
Prev close $2.86

HYPD analyst rating

BuyConsensus of 3 analysts over the last 12 months. 100% rate it a buy.
  • Strong buy0
  • Buy3
  • Hold0
  • Underperform0
  • Sell0

12-month price target · 4 analysts

Average $10.02 (+236.9% upside)

Low
$8.53
Now
$2.98
High
$11.76

Upgrades and downgrades

The latest rating actions, newest first

HYPD analyst upgrades, downgrades and rating actions
FirmDateActionRating
Cantor FitzgeraldSep 10, 2026MaintainsOverweight
Chardan CapitalSep 8, 2026MaintainsBuy
Chardan CapitalAug 13, 2026MaintainsBuy
Cantor FitzgeraldAug 13, 2026MaintainsOverweight
Chardan CapitalAug 11, 2026MaintainsBuy
Cantor FitzgeraldJul 1, 2026MaintainsOverweight
Chardan CapitalJun 8, 2026MaintainsBuy
Chardan CapitalMar 27, 2026MaintainsBuy
Chardan CapitalDec 24, 2025InitiatesBuy
Cantor FitzgeraldDec 16, 2025InitiatesOverweight

The case for and against

Updated Oct 21, 2026

Bull case

Hyperion DeFi is supported by a differentiated treasury model that compounds shareholder exposure to HYPE through staking yield, validator commissions, ecosystem rewards, DeFi monetization, and yield enhancement, while recent results showed record net income of $31.0 million and Adjusted EBITDA of $53.7 million. Management raised full-year adjusted gross profit guidance to $5 million to $7 million, expects net operating cash flow breakeven in Q3, and has already begun a $20 million share buyback, signaling improving capital efficiency and conviction in intrinsic value. The bull case is further reinforced by Hyperliquid’s rising perp market share to 6.10%, the Q2 adjusted gross profit beat of $1.15 million, and structural HYPE buyback support from the AQAv2 transition and reserve-yield routing.

Bear case

Hyperion DeFi is fundamentally exposed to a concentrated treasury model in which most assets are HYPE, making shareholder returns highly dependent on a token whose price is volatile and expected to remain so over the forecast horizon. Its thesis is also weakened by regulatory and legislative uncertainty, the Hyperliquid DEX’s no-KYC structure, and the risk that limited institutional participation or U.S. access constraints could cap volumes and ecosystem growth. On top of that, the company’s need to access capital markets to buy more HYPE creates financing risk, while the current HYPE price implies a GAAP EPS loss in Q3 despite gross profit improvement and narrowing operating cash flow burn.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.